Andrews Timothy K. 4
4 · Prometheus Biosciences, Inc. · Filed Nov 16, 2021
Insider Transaction Report
Form 4
Andrews Timothy K.
General Counsel
Transactions
- Award
Stock Option (Right to Buy)
2021-11-14+54,132→ 54,132 totalExercise: $36.32Exp: 2031-11-13→ Common Stock (54,132 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option will vest on November 14, 2022, and 1/48th of the shares subject to the option will vest monthly thereafter, subject to the Reporting Person's continued service with the Issuer through each vest date.